Download PDF
CC BY-NC-ND 4.0 · Journal of Coloproctology 2023; 43(01): 043-048
DOI: 10.1055/s-0043-1764234
Review Article

Approaches in the treatment of perianal fistula in Crohn disease

Rui Li 
1   China-Japan Union Hospital, Jilin University, China
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Perianal fistula is a common complication of Crohn disease, and it is a great burden on the life and psychology of patients, but its treatment is still a difficult problem to face. In recent years, progress in the treatment of Crohn disease has progressed rapidly due to the advent of biological agents, but there has been a lack of research on perianal fistula in Crohn disease, and the direction of research has been scattered; therefore, the author reviews the traditional treatment of perianal fistula in Crohn disease in the context of the available literature and discusses emerging and potential therapeutic approaches.

Keywords

Crohn Disease - Perianal Fistula - Medical Treatment - Surgical Treatment - Stem Cells

The present work was performed at the China-Japan Union Hospital of Jilin University, China.




Publication History

Received: 27 June 2022

Accepted: 18 November 2022

Article published online:
22 March 2023

© 2023. Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Schwartz DA, Loftus Jr EV, Tremaine WJ. et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122 (04) 875-880
    CrossrefPubMedGoogle Scholar
  • 2 Adegbola SO, Dibley L, Sahnan K. et al. Burden of disease and adaptation to life in patients with Crohn's perianal fistula: a qualitative exploration. Health Qual Life Outcomes 2020; 18 (01) 370
    CrossrefPubMedGoogle Scholar
  • 3 Present DH, Rutgeerts P, Targan S. et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340 (18) 1398-1405
    CrossrefPubMedGoogle Scholar
  • 4 Panés J, García-Olmo D, Van Assche G. et al; ADMIRE CD Study Group Collaborators. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet 2016; 388 (10051): 1281-1290
    CrossrefPubMedGoogle Scholar
  • 5 Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Scand J Gastroenterol 2006; 41 (09) 1064-1072
    CrossrefPubMedGoogle Scholar
  • 6 Tonelli F, Giudici F, Asteria CR. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study. Dis Colon Rectum 2012; 55 (08) 870-875
    CrossrefPubMedGoogle Scholar
  • 7 Lansdorp CA, Gecse KB, Buskens CJ. et al. Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease. Aliment Pharmacol Ther 2021; 53 (05) 587-597
    CrossrefPubMedGoogle Scholar
  • 8 Wu KC, Liang J, Ran ZH. et al. Chinese consensus on diagnosis and treatment of inflammatory bowel disease. Zhongguo Shiyong Neike Zazhi 2018; 38 (09) 796-813
    Google Scholar
  • 9 Bernstein LH, Frank MS, Brandt LJ, Boley SJ. Healing of perineal Crohn's disease with metronidazole. Gastroenterology 1980; 79 (02) 357-365
    CrossrefPubMedGoogle Scholar
  • 10 Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 1982; 83 (02) 383-387
    CrossrefPubMedGoogle Scholar
  • 11 Thia KT, Mahadevan U, Feagan BG. et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2009; 15 (01) 17-24
    CrossrefPubMedGoogle Scholar
  • 12 Torres J, Bonovas S, Doherty G. et al. ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment. J Crohn's Colitis 2020; 14 (01) 4-22
    CrossrefPubMedGoogle Scholar
  • 13 Feuerstein JD, Ho EY, Shmidt E. et al; American Gastroenterological Association Institute Clinical Guidelines Committee. AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease. Gastroenterology 2021; 160 (07) 2496-2508
    CrossrefPubMedGoogle Scholar
  • 14 West RL, van der Woude CJ, Hansen BE. et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2004; 20 (11-12): 1329-1336
    CrossrefPubMedGoogle Scholar
  • 15 Dewint P, Hansen BE, Verhey E. et al. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut 2014; 63 (02) 292-299
    CrossrefPubMedGoogle Scholar
  • 16 McFarland LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 2008; 5 (01) 40-48
    CrossrefPubMedGoogle Scholar
  • 17 Yarur AJ, Kanagala V, Stein DJ. et al. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease. Aliment Pharmacol Ther 2017; 45 (07) 933-940
    CrossrefPubMedGoogle Scholar
  • 18 Colombel JF, Schwartz DA, Sandborn WJ. et al. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut 2009; 58 (07) 940-948
    CrossrefPubMedGoogle Scholar
  • 19 Lichtiger S, Binion DG, Wolf DC. et al. The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy. Aliment Pharmacol Ther 2010; 32 (10) 1228-1239
    CrossrefPubMedGoogle Scholar
  • 20 Schreiber S, Lawrance IC, Thomsen OO, Hanauer SB, Bloomfield R, Sandborn WJ. Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study. Aliment Pharmacol Ther 2011; 33 (02) 185-193
    CrossrefPubMedGoogle Scholar
  • 21 Feagan BG, Schwartz D, Danese S. et al. Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2. J Crohn's Colitis 2018; 12 (05) 621-626
    CrossrefPubMedGoogle Scholar
  • 22 Attauabi M, Burisch J, Seidelin JB. Efficacy of ustekinumab for active perianal fistulizing Crohn's disease: a systematic review and meta-analysis of the current literature. Scand J Gastroenterol 2021; 56 (01) 53-58
    CrossrefPubMedGoogle Scholar
  • 23 Lee MJ, Parker CE, Taylor SR. et al. Efficacy of Medical Therapies for Fistulizing Crohn's Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2018; 16 (12) 1879-1892
    CrossrefPubMedGoogle Scholar
  • 24 Ochsenkühn T, Göke B, Sackmann M. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease. Am J Gastroenterol 2002; 97 (08) 2022-2025
    CrossrefPubMedGoogle Scholar
  • 25 Sandborn WJ, Present DH, Isaacs KL. et al. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 2003; 125 (02) 380-388
    CrossrefPubMedGoogle Scholar
  • 26 Hart AL, Plamondon S, Kamm MA. Topical tacrolimus in the treatment of perianal Crohn's disease: exploratory randomized controlled trial. Inflamm Bowel Dis 2007; 13 (03) 245-253
    CrossrefPubMedGoogle Scholar
  • 27 Takesue Y, Ohge H, Yokoyama T, Murakami Y, Imamura Y, Sueda T. Long-term results of seton drainage on complex anal fistulae in patients with Crohn's disease. J Gastroenterol 2002; 37 (11) 912-915
    CrossrefPubMedGoogle Scholar
  • 28 Thornton M, Solomon MJ. Long-term indwelling seton for complex anal fistulas in Crohn's disease. Dis Colon Rectum 2005; 48 (03) 459-463
    CrossrefPubMedGoogle Scholar
  • 29 van Koperen PJ, Safiruddin F, Bemelman WA, Slors JF. Outcome of surgical treatment for fistula in ano in Crohn's disease. Br J Surg 2009; 96 (06) 675-679
    CrossrefPubMedGoogle Scholar
  • 30 van der Hagen SJ, Baeten CG, Soeters PB, van Gemert WG. Long-term outcome following mucosal advancement flap for high perianal fistulas and fistulotomy for low perianal fistulas: recurrent perianal fistulas: failure of treatment or recurrent patient disease?. Int J Colorectal Dis 2006; 21 (08) 784-790
    CrossrefPubMedGoogle Scholar
  • 31 Rozalén V, Parés D, Sanchez E. et al. Advancement Flap Technique for Anal Fistula in Patients With Crohn's Disease: A Systematic Review of the Literature. Cir Esp 2017; 95 (10) 558-565
    PubMedGoogle Scholar
  • 32 van Praag EM, Stellingwerf ME, van der Bilt JDW, Bemelman WA, Gecse KB, Buskens CJ. Ligation of the Intersphincteric Fistula Tract and Endorectal Advancement Flap for High Perianal Fistulas in Crohn's Disease: A Retrospective Cohort Study. J Crohn's Colitis 2020; 14 (06) 757-763
    CrossrefPubMedGoogle Scholar
  • 33 Gingold DS, Murrell ZA, Fleshner PR. A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn's disease. Ann Surg 2014; 260 (06) 1057-1061
    CrossrefPubMedGoogle Scholar
  • 34 Grimaud JC, Munoz-Bongrand N, Siproudhis L. et al; Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif. Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease. Gastroenterology 2010; 138 (07) 2275-2281 , 2281.e1
    CrossrefPubMedGoogle Scholar
  • 35 Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol 2002; 13 (05) 377-383
    CrossrefPubMedGoogle Scholar
  • 36 Senéjoux A, Siproudhis L, Abramowitz L. et al; Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif [GETAID]. Fistula Plug in Fistulising Ano-Perineal Crohn's Disease: a Randomised Controlled Trial. J Crohn's Colitis 2016; 10 (02) 141-148
    CrossrefPubMedGoogle Scholar
  • 37 Adamina M, Bonovas S, Raine T. et al. ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment. J Crohn's Colitis 2020; 14 (02) 155-168
    CrossrefPubMedGoogle Scholar
  • 38 Zhou C, Li M, Zhang Y. et al. Autologous adipose-derived stem cells for the treatment of Crohn's fistula-in-ano: an open-label, controlled trial. Stem Cell Res Ther 2020; 11 (01) 124
    CrossrefPubMedGoogle Scholar
  • 39 DelaRosa O, Dalemans W, Lombardo E. Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases. Curr Opin Biotechnol 2012; 23 (06) 978-983
    CrossrefPubMedGoogle Scholar
  • 40 Yamamoto T, Allan RN, Keighley MR. Effect of fecal diversion alone on perianal Crohn's disease. World J Surg 2000; 24 (10) 1258-1262 , discussion 1262–1263
    CrossrefPubMedGoogle Scholar
  • 41 Gu YF, Wu XJ, Chen Y. Experts consensus on the diagnosis and treatment of perianal fistulzing Crohn's disease. Chin J Inflamm Bowel Dis 2019; 3 (02) 105-110
    Google Scholar
  • 42 Fosen KM, Thom SR. Hyperbaric oxygen, vasculogenic stem cells, and wound healing. Antioxid Redox Signal 2014; 21 (11) 1634-1647
    CrossrefPubMedGoogle Scholar
  • 43 Lansdorp CA, Buskens CJ, Gecse KB. et al. Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease: Results of the HOT-TOPIC trial after 1-year follow-up. United European Gastroenterol J 2022; 10 (02) 160-168
    CrossrefPubMedGoogle Scholar